anidulafungin has been researched along with Hematologic Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, TS; Chim, CS; Gill, H; Hwang, YY; Khong, PL; Kwong, YL; Leung, AY; Lie, AK; Loong, F; Sim, J; Tse, AC; Tse, E | 1 |
| Aarnoutse, RE; Brüggemann, RJ; Burger, DM; Lempers, VJ; Muilwijk, EW; Pickkers, P; Warris, A | 1 |
| Cuenca-Estrella, M; Gurguí, M | 1 |
| Ruiz Camps, I; Vázquez López, L | 1 |
3 review(s) available for anidulafungin and Hematologic Diseases
| Article | Year |
|---|---|
Impact of special patient populations on the pharmacokinetics of echinocandins.
Topics: Adolescent; Adult; Anidulafungin; Antifungal Agents; Candida; Caspofungin; Child; Critical Illness; Drug Interactions; Echinocandins; Hematologic Diseases; Humans; Infant, Newborn; Kidney; Lipopeptides; Liver; Micafungin; Microbial Sensitivity Tests; Obesity | 2015 |
[Current status of invasive fungal infections. New diagnostic techniques and antifungal agents].
Topics: Anidulafungin; Antifungal Agents; Aspergillosis; beta-Glucans; Candidiasis; Clinical Trials as Topic; Critical Care; Diabetes Complications; Disease Susceptibility; Echinocandins; Fungemia; Galactose; Hematologic Diseases; Humans; Immunocompromised Host; Mannans; Meta-Analysis as Topic; Mycoses; Neoplasms; Opportunistic Infections | 2008 |
[Potential of anidulafungin in hematological patients].
Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Azoles; Candidiasis; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Therapy, Combination; Echinocandins; Fungemia; Hematologic Diseases; Hematologic Neoplasms; Humans; Inactivation, Metabolic; Kidney Diseases; Liver Diseases; Mice; Neutropenia; Risk Factors | 2008 |
1 other study(ies) available for anidulafungin and Hematologic Diseases
| Article | Year |
|---|---|
Breakthrough invasive fungal diseases during echinocandin treatment in high-risk hospitalized hematologic patients.
Topics: Adenine Nucleotides; Adult; Anidulafungin; Antibiotic Prophylaxis; Antifungal Agents; Antimetabolites, Antineoplastic; Arabinonucleosides; Candida; Candidiasis, Invasive; Caspofungin; China; Clofarabine; Cohort Studies; Cross Infection; Echinocandins; Fusariosis; Fusarium; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Lipopeptides; Lung Diseases, Fungal; Micafungin; Retrospective Studies; Risk Factors | 2014 |